Leuprolide Acetate (C09-0935-627)

InformationLeuprolide Acetate Leuprolide acetate (Leuprorelin) is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist used for diverse clinical applications, including the treatment of prostate cancer, endometriosis, utIn vitroLeuprolide acetate is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist. Leuprolide acetate suppresses gonadotrope secretion of luteinizing hormone and follicle-stimulating hormone that subsequently suppresses gonadal sex steroid production.In vivoLeuprolide acetate is used for diverse clinical applications, including the treatment of prostate cancer, endometriosis, uterine fibroids, central precocious puberty and in vitro fertilization techniques. Leuprolide acetate is presently being tested for the treatment of Alzheimer/'s disease, polycystic ovary syndrome, functional bowel disease, short stature, premenstrual syndrome and even as an alternative for contraception. Leuprolide acetate is considered to be a very safe and tolerable drug.Cell Datacell lines：Concentrations：10−6 M or 10−11 MIncubation Time：6, 12, 18, 24 and 30 days.Powder Purity:≥99%. Specification: 10mM in DMSO Molecular Formula: C59H84N16O12·C2H4O2 Molecular Weight: 1269.45